0115 966 7955 Today's Opening Times 10:00 - 20:00 (GMT)
Place an Order
Instant price

Struggling with your work?

Get it right the first time & learn smarter today

Place an Order
Banner ad for Viper plagiarism checker

How Does Technological Advancement Eliminate Genetic Disease

Disclaimer: This work has been submitted by a student. This is not an example of the work written by our professional academic writers. You can view samples of our professional work here.

Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of UK Essays.

Published: Fri, 15 Sep 2017

Amy Chong

How Do Technological Advancement, Combined With Our Extensive Knowledge From The Human Genome Project, Help Us To Eliminate Genetic Diseases?

Abstract

The aim of this project is to answer the question ‘how do technological advancements, combined with our extensive knowledge from the Human Genome Project, help us to eliminate genetic diseases?’ I want to find out more about genetic diseases, such as Myotonic Dystrophy and Cystic Fibrosis, and the stage that scientists are at in curing patients. I’ll explore the ethical issues of possible ‘gene editing’ in the future. I’ve carried out a lot of research on the background of genetic diseases and one could speculate that gene editing could eliminate diseases within the next decade or two, if technologies continue to expand at the current rate. This report has enabled me to recognise the work of scientists and furthermore, encouraged me to pursue a career in STEM[DS1].

 

Introduction

History of the Human Genome Project

The Human Genome Project was a ground breaking discovery in the understanding of how we evolved as human beings (Carey, 2015). Their aim was to map and understand all the genes for building human beings by going through 3.2 billion bases. A genome can be defined as “an organism’s complete set of DNA, including all of its genes” (Genetics Home Reference, 2016). This research has clearly revolutionised genetics as the cost of gene editing and testing has decreased by 99 percent (Kurzgesagt, 2015[DS2]).

Methodology

My research is based on secondary qualitative research from published journals, scientific reports and books. It didn’t cost any money to conduct. I’ve approached my question through Jennifer Doudna’s lens on future technology such as CRISPR to eliminate disease. “They’re all diseases that have known genetic causes, and we now have the technology that can repair those mutations.” (Jennifer Doudna, 2016). I’ll apply CRISPR in contrast to current technologies used.

DNA Coding

What is the genetic code?

DNA is made up of many nucleotides containing three molecules: a deoxyribose pentose sugar, a phosphate group and a nitrogenous organic base. These bases are Cytosine (C), Adenine (A), Thymine (T) and Guanine (G) (Toole, 2015).

IMG_256How does genetic codes link to genetic diseases?

Three bases code for an amino acid. The code is non-overlapping which reveals there’s only twenty different amino acids present in proteins. Changes to the base sequence or quantity results in a ‘mutation’. There are four types of mutations that can occur during DNA semi-conservative replication: nonsense, missense, silent and frame shift. Any of these changes to the DNA sequence leads to ‘gene mutation'(Toole, 2015). This is shown in figure one.

Figure one – Effects of single base mutation In DNA Code[DS3].

Myotonic Dystrophy

From the Genome Project, it’s evident that the isolation of a number of genes is associated with Myotonic Dystrophy. Myotonic Dystrophy is a dominant disorder. Patients suffer from prolonged contractions, therefore are unable to relax their muscles (Genetics Home Reference,2016). The symptoms start to appear during adulthood. According to the Congenital Myotonic Dystrophy in Britain research, (1975) there are two types of Myotonic Dystrophy. Type one involves weak muscles affecting the lower legs, hands, neck, and face. Whereas type two is associated with the muscles of the neck, shoulders, elbows, and hips. The two differ due to mutations in different genes (Harper, 1975).

Figure two (in appendices) reveals the muscle strength of those who suffer from this disease in contrast to a person, with average height and build, with the muscle strength of 38kg (Grassino etal.,1997:135).

How does Myotonic Dystrophy differ from other genetic diseases?

This genetic disease has different characteristics to a ‘typical dominant disorder’. Normally, the symptoms of genetic diseases don’t get worse when they are passed on from parent to child. This is the case with Myotonic Dystrophy. The disease is unique due to the gene containing small sequences of DNA that’s repeated multiple of times. Type 1 is caused by a mutation in the ‘DMPK gene,’ which appears to regulate the production and function of structures inside muscle cells. The mutated DMPK gene contains three DNA nucleotides – CTG – repeated in the ranges from 5 to 34. On the other hand, type two is caused by ‘CNBP gene’. This consist of four DNA nucleotides – CCTG – repeated fewer than 26 times (Carey, 2015).

What technologies have been made to eliminate Myotonic Dystrophy?

Currently, there’s no cure or specific treatment for Myotonic Dystrophy but there is ‘a promising step forward toward muscular Dystrophy treatment’ (the University of Rochester Medical Centre, 2012). Their research involves reversing the symptoms by creating synthetic compounds that will eliminate a buildup of toxic RNA in muscle cells. This was tested on mice and results showed that symptoms were reduced for up to one year. According to Charles Thorntom (2012), “these results give us strong encouragement about the possibility of developing a treatment.” Is testing mice the best research method? How will we know if the research would eliminate the genetic disease in humans[DS4]?

What are the implications of the research?

As the cure is still to be found, it is not possible to test on humans due to “limitless RNA targets involved in disease; the question is how to find small molecules that bind to them,” (Disney,2012). Because of ‘limitless RNA targets,’ it complicates the target amplification system. This is an enzyme-medicated process, therefore, millions of targeted enzymes are copied within several hours; the copies made would be used for research. As a result, the techniques are sensitive to contamination. This could lead to false-positive reactions which cause implications for future research (McClatchey, 2002).

What has been done to prevent ‘false-positive reactions?’

Perhaps the University of Rochester Medical Center should consider using Kaspersky Lab technology to test for false-positive reactions. The machine can automatically create files for results that are common or not. Results that are not common are ignored and won’t affect research. This upgrade in technology would make their results more clear (Kaspersky Lab, 2015). But should they accept the false positive results as side effects of their research? Could these false positive results be significant in their research?

Cystic Fibrosis   

Cystic fibrosis is an inherited disease causing a build up of mucus to damage the body’s organs. Mucus is a lubricant that protects the linings of the airways and digestive system. People with cystic fibrosis, produces thick mucus that clogs the airways causing problems with breathing. Over time, it can permanently damage the lungs by producing scar tissues. Scar tissues are thicker and less elastic than normal tissues so the tidal volume is reduced (Genetics Home Reference, 2016).

Which codes causes Cystic Fibrosis?

If you’re missing two letters out of 3.2 billion of the sequence, ATT CTT GATT, you have cystic fibrosis (Sabatini,2016). Mutation in the CFTR gene disrupts the flow of chloride ions across cell membrane, which is necessary to produce freely flowing mucus (Genetics Home Reference, 2016).

What technologies have been made to eliminate Cystic Fibrosis?

From the Human Genome Project, we know which genome codes for lungs, and with the help of stem cells and tissue engineering, scientist believe it is possible for human lungs to be ‘successfully grown in a lab for the first time,’ (Medical News Today, 2014). Due to shortage of donor organs, using stem cells (which are able to differentiate in to other cells) is a desirable approach for organ replacement. Whilst the field of tissue engineering has successfully reconstructed cartilage frameworks for ears and bones in the skull and face; they struggle to use stem cells to grow lungs that’ll survive and function properly (Lui etal.,2013). This means maintaining blood and oxygen supply inside the body without clotting (The Guardian, 2015). Will growing organs give a better quality of life to those who suffer from Cystic Fribrosis? Would this be as effective as gene editing technology?

Gene Editing Technology

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)

CRISPR-Cas9 is a technology, using bacteria, that enables parts of the genome to be cut out and replaced, or to add parts of DNA sequence.The CRISPR-Cas9 system consists of two key molecules: enzyme Cas9 (a ‘molecular scissors’ that cuts a specific location of DNA) and RNA (The New York Times, 2015).

Figure three (in appendices) will show the steps of gene editing. Once the DNA is edited, the mutation causing the genetic disease would be eliminated (Your Genome, 2016).

Technology success

Layla recovered from leukaemia thanks to gene-editing technology. ‘For children as young as Layla, the cure rates are only 25 per cent’ (Sujith Samarasinghe, 2015). As a result, her doctors proceed to ‘gene therapy’ to removing immune cells from her body and genetically engineer them to attack cancerous cells (Nature, 2015). She received T-cells (exposed to a DNA-cutting enzyme called a TALEN) from a healthy donor. The process was done so that the modified T-cells injected were not recognised as ‘foreign.’ T-cells are significant because receptor – CAR19 – helps programs the T-cells to kill any cells with protein – CD19 – found on cancer cells. Is the process this simple?

There’s a risk of the enzyme being cut the wrong place resulting cells turning cancerous (New Scientist, 2015). Research on gene editing is now expanding to minimise this risk. Soon “there are a whole bunch of other disorders we cure” (Qasim, 2015). Since she is the first person to be cured using gene editing does this mean it’s safe to proceed this process on other diseases?

Ethical Issues

Objective of Gene Editing

As the technology is at its early stages, scientist are creating a modified version of Cas9 that’ll change specific letters to remove the mutation that caused genetic disease. In most eyes, gene editing is unjust since the technology is limited to individuals. Researchers are mainly testing on reproductive cells to prevent children from having the condition. They’re plan to carry human trial by the end of 2016. Do we know enough information for humans to participate as the effects are unpredictable? (Your Genome, 2015).

Future Generations

According to David Baltimore (2015) ‘we sense that we are close to being able to alter human heredity.’ CRISPR is opposed by a lot of people as they want new laws and regulations to protect the human gene pool of our entire species. The process is irreversible. If technology advancement and researchers have enough information to create modified humans, we have to consider the cost. This is a valid point as wealthy parent maybe tempted to treat unwanted characteristics that are not actually diseases. Do we want stronger, smarter, taller children with specific colour eyes? Could designer babies be the answer to eliminate genetic diseases? These are the questions that pose potential flaws is the advancement of technology[DS5].

Conclusion

Gene editing research and technology advancement is the step forward in eliminating genetic diseases. From my selective mention of genetic diseases such as Myotonic Dystrophy and Cystic Fibrosis, we can see technologies such as growing organs using stem cells and synthesis of compounds to cure disease are making progress. The focus of gene editing will an effective treatment if the trials are successful. This is the beginning of revolutionising human genome and eliminating genetic disease as a whole.

References

Carey.N, (2015). Junk DNA. London: Icon Books Ltd. Pages 7-11.

CNBC, (2016). Editing our genes to cure – not just treat – disease. [Online] Available at: http://www.cnbc.com/2016/05/26/editing-our-genes-to-cure–not-just-treat–disease.html [Accessed 31 Aug. 2016].

Genetic Home Reference, (2016). Myotonic Dystrophy. [Online] Available at: https://ghr.nlm.nih.gov/condition/myotonic-dystrophy [Accessed 29 Aug. 2016].

Genetic Home Reference, (2016). What is a genome? [Online] Available at: https://ghr.nlm.nih.gov/primer/hgp/genome [Accessed 20 Aug. 2016].

Grassino etal. (1997). Relationship Between Chronic Hypercapnia and Inspiratory-Muscle Weakness in Myotonic Dystrophy. Am J Respir Crit Care Med, [Online] Volume(158), pages 133-137. Available at:

http://www.atsjournals.org/doi/full/10.1164/ajrccm.156.1.9509041#readcube-epdf [Accessed 31 Aug. 2016].

Harper,P. (1975). Congenital myotonic dystrophy in Britain. Archives of Disease in Childhood, [Online] Volume(50), pages 505-513. Available at:

http://adc.bmj.com/content/50/7/505.full.pdf [Accessed 29 Aug. 2016].

Kaspersky, (2015). Kaspersky Lab Patents Automated False-Positive Testing Technology Based on Machine Learning Algorithms. [Online] Available at: http://www.kaspersky.com/about/news/product/2015/Kaspersky-Lab-Patents-Automated-False-Positive-Testing-Technology-Based-on-Machine-Learning-Algorithms [Accessed 29 Aug. 2016].

Kurzgesagt – In a Nutshell, (2016). Genetic Engineering Will Change Everything Forever – CRISPR. [Online] Available at: https://www.youtube.com/watch?v=jAhjPd4uNFY [Accessed 11 Aug. 2016].

Live Science, (2013). DNA: Definition, Structure & Discovery. [Online] Available at: http://www.livescience.com/37247-dna.html [Accessed 20 Aug. 2016].

Lui, Yunying etal.(2013) Generation of functional organs from stem cells. BioMed Central, Page 1.

McClatchey,K. (2002). Clinical Laboratory Medicine. 2nd Edition. Philadelphia: Lippincott Williams & Wilkins, Page 1237.

Medical News Today, (2014). Human lungs successfully grown in a lab for the first time. [Online] Available at: http://www.medicalnewstoday.com/articles/272763.php [Accessed 29 Aug. 2016].

Myotonic Dystrophy Foundation, (2012).SCIENTISTS CREATE POTENT MOLECULES AIMED AT TREATING MYOTONIC DYSTROPHY. [Online] Available at: http://www.myotonic.org/scientists-create-potent-molecules-aimed-treating-myotonic-dystrophy [Accessed 29 Aug. 2016].

National Human Genome Research Institute, (2012). A New Five-Year Plan for the United States: Human Genome Program. [Online] Available at: https://www.genome.gov/10001476/human-genome-projects-fiveyear-plan-19931998/ [Accessed 29. Aug. 2016].

Nature, (2015). Leukaemia success heralds wave of gene-editing therapies. [Online] Available at: http://www.nature.com/news/leukaemia-success-heralds-wave-of-gene-editing-therapies-1.18737 [Accessed 31 Aug. 2016].

New Scientist, (2015). Gene editing saves girl dying from leukaemia in world first. [Online] Available at: https://www.newscientist.com/article/dn28454-gene-editing-saves-life-of-girl-dying-from-leukaemia-in-world-first/ [Accessed 31 Aug. 2016].

Openstax CNX, (2016). DNA Repair. [Online] Available at: https://cnx.org/contents/[email protected]/DNA-Repair [Accessed 20 Aug. 2016].

Science Daily, (2015).Potential treatment identified for myotonic muscular dystrophy. [Online]. Available at: https://www.sciencedaily.com/releases/2015/03/150318140652.htm [Accessed 29 Aug. 2016].

Toole,G. and Toole,S. (2015). A Level AQA Biology. 2nd Edition. Glasgow: Bell and Bain Ltd. Pages 36-37, 202-203.

University of Rochester Medical Center, (2012). A Promising Step Forward Toward Muscular Dystrophy Treatment. [Online] Available at: https://www.urmc.rochester.edu/news/story/3572/a-promising-step-forward-toward-muscular-dystrophy-treatment.aspx [Accessed 29 Aug. 2016].

Wellcome Trust Sanger Institute, (2001). Ten facts from the Human Genome Project. [Online] Available at: http://www.sanger.ac.uk/news/view/ten-facts-human-genome-project [Accessed 20 Aug. 2016].

Your Genome, (2015). Is germline gene therapy ethical? [Online] Available at: http://www.yourgenome.org/debates/is-germline-gene-therapy-ethical [Accessed 31 Aug. 2016].

Your Genome, (2016). What is CRISPR-Cas9? [Online] Available at: http://www.yourgenome.org/facts/what-is-crispr-cas9 [Accessed 31 Aug. 2016].

Appendices

Figues and diagram

Figure two – Results of muscle weakness in Myotonic Dystrophy patients in contrast to those who don’t have the disease.

pic

Figure three – The stages of using bacteria to edit DNA sequence.

Gantt Chart

Glossary

Deoxyribonucleic acid (DNA) – a molecule that is consist of instructions for an organism needs to develop, live and reproduce.

Non-overlapping – each base in the sequence is read one.

Dominant allele – the disease is present even if the individual only has one copy of the allele.

Ribonucleic acid (RNA) – a messenger carrying single stranded instructions from DNA to control protein synthesis.

Enzyme-medicated process – single enzyme or multiple enzymes synthesis copies of nuclei acid.

False positive – A result that indicates that a given condition is present when it is not.

Cell membrane – the partially permeable membrane surrounding the cytoplasm of a cell.

Stem cells – an undifferentiated cell of a multicellular organism which has the ability to differentiate to repair and replace damaged tissues and organs.

Tissue -  group of similar cells working together to perform a special function.

Organ – Combination of tissues that are coordinated to perfrm a variety of functions. Eg. Heart, lungs.

T- Cells – Type of lympocyte matured in the thymus gland that is involved in humoral immunity.

Enzyme – a protein with a specific active site and tertiary structure. It acts as a biological catalyst to bring about a biochemical reaction.

Cas9 – a protein that guides the RNA to enter cells without undergoing transcription and translation.


[DS1]Good start. In future, try to practice academic language. Such as “This paper will…” or “The research in this paper will discuss…” avoid using I, me, we my etc.

[DS2]Good.

[DS3]Good

[DS4]Excellent points raised.

[DS5]Good point


To export a reference to this article please select a referencing stye below:

Reference Copied to Clipboard.
Reference Copied to Clipboard.
Reference Copied to Clipboard.
Reference Copied to Clipboard.
Reference Copied to Clipboard.
Reference Copied to Clipboard.
Reference Copied to Clipboard.

Request Removal

If you are the original writer of this essay and no longer wish to have the essay published on the UK Essays website then please click on the link below to request removal:


More from UK Essays